ACB $6.920 (-1.56%)

ACNNF $0.060 (-13.92%)

AERO $3.210 (0%)

ALEAF $0.226 (-0.62%)

AMMJ $0.100 (-0.1%)

APHA $15.380 (0%)

ARNA $61.410 (-2.35%)

ATT:CNX $0.080 (0%)

ATTBF $0.004 (-9.09%)

AUSA:CNX $0.170 (-5.56%)

AUSAF $0.141 (-5.32%)

AVXL $17.760 (1.37%)

BAMM:CNX $0.490 (-1.01%)

BBM:CNX $0.085 (0%)

BBRRF $0.065 (-2.26%)

BE:CNX $0.005 (0%)

BIO:CNX $0.040 (-5.88%)

BLEVF $0.003 (0%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.720 (2.86%)

BLOZF $0.582 (2.61%)

BUDZ $0.296 (-0.8%)

CADMF $0.114 (-9.88%)

CALI:CNX $0.065 (-7.14%)

CANN $0.386 (-4.64%)

CARA $12.720 (-3.34%)

CBWTF $0.171 (0.29%)

CGC $13.200 (-1.12%)

CGRW $0.071 (-8.32%)

CHOO:CNX $0.060 (-7.69%)

CHOOF $0.049 (1.67%)

CNBX $0.140 (0.14%)

CNGGF $0.210 (1.18%)

CODI $29.860 (-0.8%)

CPMD $0.031 (-10.57%)

CRBP $1.020 (0%)

CRON $5.360 (-2.19%)

CROP:CNX $0.015 (0%)

CRXPF $0.027 (0%)

CSI:CNX $0.140 (-9.68%)

CURR $0.590 (-15.65%)

CVSI $0.236 (-4.92%)

DIGP $0.035 (17.28%)

EAT:CNX $0.120 (0%)

EEVVF $0.147 (-1.28%)

EMHTF $0.088 (8.02%)

EPWCF $0.330 (-4.01%)

EVIO $0.001 (5.56%)

FFRMF $0.008 (-59.5%)

FFT:CNX $0.040 (0%)

FNNZF $0.054 (3.8%)

GNBT $0.160 (-4%)

GRIN:CNX $0.145 (0%)

GRWG $22.100 (0.87%)

GTBIF $22.850 (-3.67%)

GTII:CNX $28.300 (-3.9%)

GWPH $218.960 (0%)

HEXO $1.690 (-2.31%)

HHPHF $0.111 (-13.8%)

HLSPY $0.363 (0%)

HMLSF $5.934 (-0.78%)

HMPPF $0.498 (0%)

HRVOF $0.056 (-6.5%)

HSTRF $0.210 (-4.15%)

HUGE:CNX $1.770 (-2.21%)

IAN:CNX $0.215 (-6.52%)

IGC $1.460 (0%)

IGXT $0.606 (6.32%)

IIPR $240.820 (0.74%)

INQD $0.016 (-6.98%)

IONC:CNX $0.090 (-5.26%)

IONKF $0.070 (-9.26%)

ISOL:CNX $0.035 (0%)

ISOLF $0.001 (0%)

ITHUF $0.175 (-5.56%)

KALTF $0.210 (0%)

KHRNF $0.215 (-5.16%)

KSHB $0.695 (0%)

LHS:CNX $1.470 (0%)

LHSIF $1.145 (0%)

LXX:CNX $8.400 (0%)

MCIG $0.028 (0%)

MEDIF $0.205 (-5.6%)

MJ:CNX $0.245 (-3.92%)

MJNA $0.025 (-2.71%)

MNTR $0.104 (0.19%)

MYM:CNX $0.140 (0%)

MYMMF $0.106 (0%)

NCNNF $0.058 (0%)

NDVAF $0.355 (2.04%)

NGW:CNX $0.415 (-3.49%)

NRXCF $0.069 (0%)

NSPDF $0.032 (14.7%)

NVTQF $0.829 (8.8%)

NWKRF $0.424 (0%)

NXGWF $0.340 (-1.51%)

NXTTF $0.092 (3.49%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

PHCG $0.300 (-3.26%)

PHVAF $0.038 (0%)

PILL:CNX $0.700 (0%)

PKG:CNX $0.095 (-5%)

PLPRF $0.357 (0%)

PLUS:CNX $0.440 (0%)

PMCB $3.010 (-0.99%)

PNPL $0.005 (0%)

PRCNF $0.003 (0%)

PTNYF $0.081 (2.66%)

QCA:CNX $0.170 (6.25%)

RDDTF $0.044 (-5.15%)

RLLVF $0.012 (0%)

RMHB $0.005 (0%)

RQB:CNX $0.005 (0%)

RQHTF $0.936 (5.3%)

SLNG:CNX $0.165 (0%)

SMG $148.290 (-0.04%)

SNN:CNX $0.155 (0%)

SOL:CNX $3.290 (-3.24%)

SOLCF $2.700 (-2.03%)

SPLIF $0.092 (-3.68%)

SPRWF $0.268 (0%)

SRNA $0.055 (-4.72%)

STEM:CNX $0.290 (0%)

STMH $0.228 (-2.13%)

SUN:CNX $0.150 (0%)

TBPMF $0.186 (-2.1%)

TCAN:CNX $0.700 (-2.78%)

TCNAF $0.570 (0%)

TER:CNX $7.160 (-2.45%)

TGEN $1.760 (-0.06%)

TGIF:CNX $0.080 (6.67%)

TGIFF $0.064 (9.28%)

THC:CNX $0.090 (0%)

THCBF $0.074 (1.51%)

TLRY $10.070 (-1.66%)

TOKI:CNX $0.020 (0%)

TRLFF $0.198 (0.46%)

TRSSF $5.790 (-3.12%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.105 (5%)

VPRB $0.045 (8.24%)

VRT:CNX $0.450 (0%)

VRTHF $0.170 (275.83%)

VVCIF $0.071 (2.82%)

WAYL:CNX $0.740 (0%)

WLDFF $0.140 (0%)

XXII $2.890 (-0.34%)

ZDPY $0.865 (-1.69%)

ZYNE $3.900 (-3.94%)

Technical420 Site Search

Returned 47 result(s).

The Largest Acquisition In Cannabis Sector History Has Closed

Last week, marked another milestone of the legal cannabis industry after Jazz Pharmaceuticals (Nasdaq: JAZZ) completed the acquisition of GW Pharmaceuticals plc., a leader in the science, development and commercialization of cannabinoid-based prescription medicines. Although the acquisition did receive as much attention as the merger between Aphria and Tilray, Inc. (TLRY.TO)…

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress

GW Pharmaceuticals plc (Nasdaq: GWPH), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced financial results and operating progress for the fourth quarter and full-year ended December 31, 2020. “We are very proud of our strong financial performance and operational progress in 2020, as…

10 Major Cannabis Sector Price Target Changes Investors Need To Know

From a merger and acquisition (M&A) standpoint, the cannabis sector recently seen a spike in activity, and this is a trend that we expect to become more significant over the next few years. Last week, GW Pharmaceuticals plc (GWPH) reported to have entered into a definitive agreement with Jazz Pharmaceuticals…

GW Pharmaceuticals Multi-Billion Dollar Acquisition Just Sparked The Next Leg Higher For The Cannabis Sector

Earlier this week, the cannabis industry saw it largest acquisition in the history of the sector and this is a headline that caught the attention of major financial media firms. GW Pharmaceuticals plc (GWPH) was the target of the acquisition and it reported to have entered into a definitive agreement…

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration…

GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones

GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full year 2020 and key priorities for 2021. Justin Gover, GW’s Chief Executive Officer, expects to discuss these updates as…

When Will Big Pharma Come Knocking On GW Pharmaceuticals Door?

This week, GW Pharmaceuticals plc (GWPH) announced blowout third quarter earnings results and reported revenues that came in well above Wall Street’s expectations. The market responded favorably to the numbers and the shares jumped more than 20% higher on the day of the announcement. We want to highlight GW’s quarterly…

GW Pharmaceuticals plc Reports Third Quarter 2020 Financial Results and Operational Progress

GW Pharmaceuticals plc (Nasdaq: GWPH), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced financial results and operating progress for the third quarter ended September 30, 2020. “We are pleased to report strong revenue growth in the 3 rd quarter despite the challenges presented…

Some Of The Best Performing Stocks In The Cannabis Sector Don’t Even Touch The Plant

In 2018, the Canadian cannabis market reached peak valuations and since then the industry has been under considerable pressure. Although most cannabis companies have been under pressure, there are a handful that have executed on previously announced initiatives and are considered to be industry leaders.= One of the most interesting…

3 Cannabis Stocks We Were Right On From The Beginning

During the last decade, the legal cannabis industry has made incredible advancements as countries across the globe have legalized or decriminalized the plant. In the US, several of the largest states have legalized cannabis while it remains illegal at the federal level and this has made the investing process more…

Older Posts »

Search Again